An analysis of the effect of KRAS mutation on the expression of ACOX2 in TCGA datasets for commonly mutated cancers (Figure 5A) clearly demonstrates significant upregulation of ACOX2 mRNA in both LUAD (Figure 5B) and LUSC (Figure 5C) subtypes. Here, KRAS is linked to cancer.